Re-profiling of selected FDA approved drug(s) to induce mitochondrial biogenesis in ischemic stroke
Halima usman (5999)
Re-profiling of selected FDA approved drug(s) to induce mitochondrial biogenesis in ischemic stroke - Islamabad (unpublished) 2020 - viii, 56 p. : ill., Col. ; 30 cm. +CD
Submitted in fulfillment of the requirement for the degree of Master of Philosophy in Pharmacology to the Faculty of Pharmaceutical Sciences. Includes bibliographical references. Thesis supervisor: Dr. Fawad Ali Shah
Thesis (M.Phil)--Riphah International University, 2020
English
Pharmacology--Occlusion surgery--Molecular dynamics--Cresyl violet--Hematoxylin--RIPS
615.1 / HAL
Re-profiling of selected FDA approved drug(s) to induce mitochondrial biogenesis in ischemic stroke - Islamabad (unpublished) 2020 - viii, 56 p. : ill., Col. ; 30 cm. +CD
Submitted in fulfillment of the requirement for the degree of Master of Philosophy in Pharmacology to the Faculty of Pharmaceutical Sciences. Includes bibliographical references. Thesis supervisor: Dr. Fawad Ali Shah
Thesis (M.Phil)--Riphah International University, 2020
English
Pharmacology--Occlusion surgery--Molecular dynamics--Cresyl violet--Hematoxylin--RIPS
615.1 / HAL